The ECG telemetry devices market refers to the global market for devices that are used to monitor the electrical activity of the heart remotely. These devices are often used in clinical settings to monitor patients who have heart conditions or are undergoing heart procedures. The market for ECG telemetry devices is driven by factors such as the increasing prevalence of heart disease, the rising demand for remote patient monitoring, and the increasing adoption of wireless and mobile health technologies. Other factors contributing to the growth of the market include the development of advanced ECG telemetry devices that offer more accurate and reliable readings, as well as the increasing awareness of the benefits of early detection and treatment of heart disease. The ECG telemetry devices market is highly competitive, with a large number of companies offering a wide range of devices for various applications

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=8198

Why is Demand for Telemetric ECG Devices Rising at a Fast Pace?

1. Remote Monitoring: Telemetric ECG devices allow for remote monitoring of a patient’s heart activity, which is becoming increasingly important, especially in the wake of the COVID-19 pandemic. With remote monitoring, patients can receive care and monitoring from the safety and comfort of their own homes, reducing the risk of exposure to infectious diseases.
2. Aging Population: As the global population ages, the prevalence of cardiovascular diseases such as arrhythmias and heart failure is increasing. Telemetric ECG devices provide a non-invasive and convenient way to monitor these conditions, allowing for early detection and intervention.
3. Technological Advancements: The advancements in wearable technology and the increasing popularity of smartphones have led to the development of smaller and more sophisticated telemetric ECG devices that can be worn comfortably and discreetly. This has made it easier for patients to use and has increased the acceptance and demand for these devices.
4. Cost-Effective: Telemetric ECG devices are becoming more cost-effective, making them more accessible to patients and healthcare providers. This is especially important in regions where access to healthcare resources is limited.
5. Improved Outcomes: Studies have shown that remote monitoring using telemetric ECG devices can lead to improved outcomes for patients with cardiovascular diseases. By providing early detection and intervention, these devices can reduce the risk of hospitalization, readmission, and complications, leading to better patient outcomes and reducing the burden on healthcare systems.

Key points from the market study

• Global demand for ECG telemetry devices is expected to increase at a CAGR of 8% from 2023 to 2033.
• Sales of resting ECG devices are expected to increase at a CAGR of 9% during the forecast period.
• Demand for exercise ECG devices is projected to grow at a CAGR of 7% over the next 10 years.
• China market for ECG telemetry devices is expected to expand at a CAGR of 12% during the forecast period.

Competitive Landscape

AliveCor released the “KardiaMobile Card,” the most lightweight and portable personal ECG device, in the US in February 2022. It is the only personal ECG that can provide real-time heart health information whenever and wherever you need it and is small enough to fit in a wallet.

Key companies profiled

• Aerotel Medical Systems (1998) Ltd.
• Society for Cardiac Science
• GE Healthcare; Medtronic, Inc.
• Nihon Kohten Corporation
• Philips Healthcare
• Schaeffler AG (Schaeffler Group)
• Shenzhen Mindray Biomedical Electronics Co., Ltd.
• Siemens Healthineers
• Welch Allyn, Inc.